LegoChem Biosciences Inc
KOSDAQ:141080
Intrinsic Value
LegoChem Biosciences, Inc. engages in the development, manufacture of medicines, medical devices and medical supplies. [ Read More ]
The intrinsic value of one LegoChem Biosciences Inc stock under the Base Case scenario is 12 024.56 KRW. Compared to the current market price of 67 100 KRW, LegoChem Biosciences Inc is Overvalued by 82%.
Valuation Backtest
LegoChem Biosciences Inc
Run backtest to discover the historical profit from buying and selling LegoChem Biosciences Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
LegoChem Biosciences Inc
| Current Assets | 134.6B |
| Cash & Short-Term Investments | 45.6B |
| Receivables | 68.3B |
| Other Current Assets | 20.6B |
| Non-Current Assets | 54.9B |
| Long-Term Investments | 17.3B |
| PP&E | 25.4B |
| Intangibles | 6.9B |
| Other Non-Current Assets | 5.2B |
| Current Liabilities | 37.1B |
| Accounts Payable | 7.1B |
| Accrued Liabilities | 11.4B |
| Short-Term Debt | 11.8B |
| Other Current Liabilities | 6.8B |
| Non-Current Liabilities | 4.2B |
| Long-Term Debt | 528.4m |
| Other Non-Current Liabilities | 3.7B |
Earnings Waterfall
LegoChem Biosciences Inc
|
Revenue
|
34.1B
KRW
|
|
Cost of Revenue
|
-16.3B
KRW
|
|
Gross Profit
|
17.8B
KRW
|
|
Operating Expenses
|
-98.6B
KRW
|
|
Operating Income
|
-80.8B
KRW
|
|
Other Expenses
|
7.1B
KRW
|
|
Net Income
|
-73.7B
KRW
|
Free Cash Flow Analysis
LegoChem Biosciences Inc
Profitability Score
Profitability Due Diligence
LegoChem Biosciences Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
LegoChem Biosciences Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
LegoChem Biosciences Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
LegoChem Biosciences Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
LegoChem Biosciences Inc
According to Wall Street analysts, the average 1-year price target for LegoChem Biosciences Inc is 102 000 KRW with a low forecast of 101 000 KRW and a high forecast of 105 000 KRW.
Shareholder Return
Price
LegoChem Biosciences Inc
| Average Annual Return | 32.19% |
| Standard Deviation of Annual Returns | 96.65% |
| Max Drawdown | -38% |
| Market Capitalization | 2.4T KRW |
| Shares Outstanding | 36 025 700 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
LegoChem Biosciences, Inc. engages in the development, manufacture of medicines, medical devices and medical supplies. The company is headquartered in Daejeon, Daejeon and currently employs 116 full-time employees. The company went IPO on 2013-05-10. The firm principally involves in the development of new drugs, including antibiotics, anticoagulants, anticancer, antiplatelet, anti-inflammatory, as well as antibody-drug-conjugates (ADC), among others. The firm operates its business through technology transfer, joint and contact research and research services.
Contact
IPO
Employees
Officers
The intrinsic value of one LegoChem Biosciences Inc stock under the Base Case scenario is 12 024.56 KRW.
Compared to the current market price of 67 100 KRW, LegoChem Biosciences Inc is Overvalued by 82%.
You don't have any saved screeners yet
